MGP Ingredients investors encouraged to contact Brandon Walker for legal options.

Bragar Eagel & Squire is investigating potential claims against MGP Ingredients, Inc. (NASDAQ: MGPI) on behalf of long-term stockholders following a class action complaint filed on December 16, 2024. The investigation concerns whether the board of directors of MGPI have breached their fiduciary duties to the company. Those who suffered losses in MGPI between May 4, 2023 through October 30, 2024 are encouraged to contact Brandon Walker or Marion Passmore at (212) 355-4648 to discuss their options.

New York, Sept. 12, 2025 - Bragar Eagel & Squire, P.C., a leading stockholder rights law firm, has announced an investigation into potential claims against MGP Ingredients Inc. (NASDAQ: MGPI) on behalf of long-term stockholders. The investigation follows a class action complaint filed on December 16, 2024, alleging that the board of directors may have breached their fiduciary duties to the company.

The investigation, led by partner Brandon Walker, focuses on whether the board's decisions have negatively impacted the company and its shareholders. Those who suffered losses in MGPI between May 4, 2023, and October 30, 2024, are encouraged to contact Brandon Walker or Marion Passmore at (212) 355-4648 to discuss their options.

The complaint alleges that the board's actions, including decisions on revenue management and operating margins, have led to a significant decrease in the company's stock price. Over the past six months, MGPI's stock price fell to $28.39, a 15.4% decline from its previous levels, while the S&P 500 climbed by 16% 3 Reasons MGPI is Risky and 1 Stock to Buy Instead^[1].

The investigation will explore whether the board's decisions were in the best interest of the company and its shareholders. This includes examining the company's revenue projections, which show a significant decline in sales over the next 12 months, and the decrease in operating margins, which dropped by 13.6 percentage points over the last year 3 Reasons MGPI is Risky and 1 Stock to Buy Instead^[1].

The announcement follows a recent report from NINGI Research, which highlighted concerns about MGPI's financial health and the potential for misleading disclosures MAREX ALERT: Bragar Eagel & Squire, P.C. is Investigating Marex Group PLC on Behalf of Marex Stockholders and Encourages Investors to Contact the Firm^[2]. The investigation aims to provide transparency and protect the rights of shareholders who may have been adversely affected by the company's actions.

Investors are advised to remain informed and consider their options. For more information or to participate in the investigation, contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire, P.C.